NCT00484783

Brief Summary

NOTES access is safe and feasible in the controlled human setting and comparable to standard-of-care surgical techniques. NOTES exploration of the abdomen provides adequate visualization comparable to laparoscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 11, 2007

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
Last Updated

December 16, 2014

Status Verified

December 1, 2014

Enrollment Period

2.4 years

First QC Date

June 7, 2007

Last Update Submit

December 12, 2014

Conditions

Keywords

Laparoscopic Surgical ProceduresEndoscopic Surgical ProceduresLaparoscopic & endoscopic procedures with a gastrotomyor opening in bladder or urethra

Outcome Measures

Primary Outcomes (1)

  • 30 day Post-op NOTES feasibility outcomes:

    * Number of successful NOTES access attempts * Number of failed NOTES access attempts * Injury to collateral organs or structures * Time to gain access to peritoneal cavity * Necessary balloon dilator size required for translumenal passage of endoscope

    30 days post-op

Secondary Outcomes (2)

  • 30 Day Post-OP Evaluation of Efficacy of NOTES access when compared to historical control groups undergoing laparoscopic access during foregut surgery

    30 Day Post-OP

  • 30 Day NOTES Post - Op Evaluation of Adequacy of Abdominal Exploration

    30 Day Post - Op

Study Arms (2)

Prospective

EXPERIMENTAL

Subjects scheduled to receive procedure

Procedure: Natural Orifice Transluminal Endoscopic Surgery (NOTES)

Historical

OTHER

Chart review control group

Procedure: Natural Orifice Translumenal Endoscopic Surgery (NOTES)

Interventions

Patients will have the standard laparoscopic procedure and the NOTES procedure will be added. The surgical procedure will require two operating teams: one led by a laparoscopic surgeon, the other by an endoscopic surgeon. During the usual course of the surgery, the flexible endoscope will be passed through the mouth urethra top gain access to the peritoneal cavity.

Also known as: NOTES Surgery
Prospective

chart review of historical data from control group

Also known as: NOTES Surgery
Historical

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing an already combined laparoscopic and endoscopic foregut procedure with general anesthesia
  • Patients undergoing a prostatectomy or cystectomy with general anesthesia
  • All patients will have a planned gastrotomy for exploration, foreign body removal, or removal of tissue, making it a contaminated case or a planned cystotomy or urethrotomy for exploration, foreign body removal or removal of tissue such as prostatectomy or bladder resection.
  • No overwhelming medical co-morbidities
  • Subject is 18 years of age or older
  • Subject is his or her own medical decision maker
  • Subject agrees to participate, fully understands content of informed consent form, and signs the informed consent form

You may not qualify if:

  • Patients undergoing a non-palliative procedure in the face of resectable adenocarcinoma of the foregut or genitourinary tract
  • Linitis Plastica
  • Evidence of Active Bowel Obstruction
  • Patients with history of oropharyngeal, esophageal, or gastric adenocarcinoma.
  • Esophageal stricture prohibiting passage of an endoscope
  • Urethral stricture prohibiting passage of an endoscope
  • Emergent Surgery
  • At any time during pre-operative or intra-operative periods, evidence of unresectability is demonstrated
  • Any intra-operative condition prior to surgical resection that results in abortion of the surgical procedure
  • Any contraindication to surgery
  • Pregnancy or actively breastfeeding women
  • Prisoners or Wards of State

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals of Cleveland Case Medical Center

Cleveland, Ohio, 44116, United States

Location

MeSH Terms

Conditions

Pyloric Stenosis, HypertrophicProstatic Diseases

Interventions

Natural Orifice Endoscopic Surgery

Condition Hierarchy (Ancestors)

Pyloric StenosisGastric Outlet ObstructionStomach DiseasesGastrointestinal DiseasesDigestive System DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Jeffrey M. Marks, MD

    University Hospitals of Cleveland/ Institute for Surgical Innovation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicpal Investigator

Study Record Dates

First Submitted

June 7, 2007

First Posted

June 11, 2007

Study Start

August 1, 2006

Primary Completion

January 1, 2009

Study Completion

January 1, 2009

Last Updated

December 16, 2014

Record last verified: 2014-12

Locations